CX157,3-fluoro-7-(2,2,2,-trifluoroethoxy)phenoxathiin-10,10-dioxide, is a reversible, selective inhibitor of MAO-A designed to have improved oral bioavailability and reduced clearance compared to previous MAO-A inhibitors of this class.
Anxiety Disorders I,
Depression I
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.